Home' Australian Pharmacist : Australian Pharmacist May 2014 Contents Australian Pharmacist May 2014 I ©Pharmaceutical Society of Australia Ltd.
CONTINUING PROFESSIONAL DEVELOPMENT
1. Post-nasal drip:
a) Presents as a cough alone in the
majority of cases.
b) Is caused by accumulation of bradykinin
and substance P.
c) May be accompanied by runny nose
and throat clearing.
d) Is characterised by post-tussive
2. Choose the CORRECT statement
about asthma-related cough.
a) Wheeze or dyspnoea may be absent.
b) Accompanying symptoms include
hoarseness and throat discomfort.
c) Cough is rarely a feature of asthma.
d) Upper airway cough syndrome is a new
term for asthma-related cough.
3. Which of the following symptoms
has been found to be highly specific
for cough associated with gastro-
oesophageal reflux disease?
b) Scratchy throat.
d) None of the above.
4. The classic presentation of whooping
a) Persistent cough with significant
dyspnoea and wheeze.
b) Mild cough with rhinorrhea and
c) Episodic cough with copious sputum
d) Intense coughing attacks with a
high-pitched sound on inspiration.
5. Choose the CORRECT statement
about pertussis prophylaxis.
a) Completion of the pertussis
immunisation schedule provides
b) A single booster dose is recommended
for adults in regular contact with young
c) Chemoprophylaxis is recommended to
reduce secondary transmission in the
d) Antibiotic treatment of pertussis is
indicated up to 4 weeks after the onset
You explain to Donald that there are
several possible causes for his persistent
cough including whooping cough,
which has become more common in
adults and adolescents in recent years.
You explain to him that it is important
he makes an appointment with his GP to
investigate the cause of his symptoms.
When Donald returns to the pharmacy
the following week, he tells you that
he had some tests performed and his
GP considered the most likely cause of
his symptoms to be whooping cough.
His doctor told him he is no longer
infectious as his cough developed more
than three weeks ago. You advise him
that he can return to work but he should
check the immunisation status of other
household members; his children should
receive catch-up doses if they have not
received the pertussis vaccine according
to the National Immunisation Program
You also mention that a
single booster dose of pertussis vaccine
(combined with diphtheria and tetanus
vaccine) is recommended for any adults
in regular contact with young children.
KEY LEARNING POINTS
• Pertussis is a prolonged coughing
illness with clinical manifestations
that vary by age.
• Adults and children may present
with a mild cough illness without the
classic inspiratory whoop.
• Pertussis is frequently under-
diagnosed and should be considered
in all adolescents and adults
presenting with persistent cough.
• People with coughing illnesses should
be encouraged to avoid contact with
infants < six months of age until a
diagnosis is made and they are no
1. Chronic persistent cough in adults [revised Jun 2011].
Patient.co.uk. At: www.patient.co.uk/doctor/chronic-
2. Braman SS. Post-infectious cough: ACCP evidence-
based clinical practice guidelines. Chest 2006;129(Suppl
3. Taliercio RM, Culver DA. Cough [revised Aug 2010].
Cleveland Clinic. At: www.clevelandclinicmeded.com/
4. Sylvester DC, Karkos PD, Vaughan C, et al. Chronic
Cough, Reflux, Postnasal Drip Syndrome, and the
Otolaryngologist. Int J Otolaryngology 2012, Article ID
5. Ojoo JC, Everett CF, Mulrennan SA, et al. Management of
patients with chronic cough using a clinical protocol: a
prospective observational study. Cough 2013;9:2.
6. Morice AH. The diagnosis and management of chronic
cough. Eur Respir J 2004; 24:481–92.
7. Gibson PG, Chang AB, Glasgow NJ, et al. CICADA: Cough in
Children and Adults: Diagnosis and Assessment. Australian
Cough Guidelines summary statement. Med J Aust
8. Matsumoto H, Niimi A, Takemura M, et al. Features
of cough variant asthma and classic asthma during
methacholine-induced brochoconstriction: a cross-
sectional study. Cough 2009;5(3):doi:10.1186/1745–9974-
9. Gaude GS. Pulmonary manifestations of gastroesophageal
reflux disease. Ann Thorac Med 2009;4(3):115–23.
10. Smith JA, Houghton LA. The oesophagus and cough:
laryngo-pharyngeal reflux, microaspiration and vagal
reflexes. Cough 2013;9:12.
11. Eastburn MM, Katelaris PH, Chang AB. Defining the
relationship between gastroesophageal reflux and cough:
probabilities, possibilities and limitations. Chest 2007;3:4.
12. Dicpinigaitis PV. Angiotensin-Converting Enzyme
Inhibitor-Induced Cough : ACCP Evidence-Based Clinical
Practice Guidelines. Chest 2006;129(1_suppl):169S–173S.
13. Assessment of chronic cough [revised Mar 2013] BMJ Best
Practice. At: http://bestpractice.bmj.com/best-practice/
14. Brugts JJ, Arima H, Bertrand M, et al. Clinical predictors
of ACE-inhibitor induced dry cough in 27492 patients
with cardiovascular disease using individual data of
randomized clinical trials. Eur Heart J 2013;34(Suppl 1).
15. 4 .12 Pertussis [revised Jan 2014].The Australian
Immunisation Handbook. 10th edn. At: www.health.
16. 16. Marchant J. Managing pertussis in adults. Aust Prescr
17. 17 . Communicable Disease Network Australia.
National Guidelines for Public Health Units:
Pertussis, Version 2. 2013. At: www.health.
18. eTG complete [Internet]. Melbourne: Therapeutic
19. Britton P & Jones CA. Pertussis prophylaxis. Australian
Prescriber 2012;35:82–4 .
20. National Immunisation Program Schedule [revised Oct
2013]. Immunise Australia Program. At: www.immunise.
Links Archive Australian Pharmacist April 2014 Australian Pharmacist June 2014 Navigation Previous Page Next Page